Resistance Analysis of Hepatitis C Virus (HCV) from Genotype 1 and 4 Treatment-naive Subjects Receiving Samatasvir in Combination with Simeprevir and Ribavirin in a 12-week Phase II Clinical Trial

HEPATOLOGY(2014)

引用 0|浏览12
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要